ClinicalTrials.govpublic full text
Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
serogroup b meningococcal meningitis, infant, meningococcal disease, prevention, vaccination, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853802
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.